About Sungen_Sungen

Please enter a keyword

About Sungen

Company Profile

Milestones

Social Responsibilities

Join Us

Research & Development

Research Platforms

Research Centers

Research Institutes

New Raw Materials of Pharmaceutical

Innovative Manufacture

Lighthouse Factory

Biofabrication

Key Control System

Quality Management

Authoritative Certification

Clinical Research

Real-World Study

Research Fund

Research Papers Published

Brand ANI

Products

Company Profile

Sungen, a company for innovation driven fermentation products, focuses on peptide drugs and biological fermentation technology. Sungen is a national high-tech enterprise, the original research and production enterprise of nattokinase and natural vitamin K2 (MK-7) in China, and the demonstration base of production quality management of physiologically active substances (such as nattokinase, natural vitamin K2 γ- Polyglutamic acid, etc.).

Sungen takes biological fermentation manufacturing as the core, covering the fields of new drugs, nutrition and health products, skin care products and so on. It has a whole industrial chain of strain fermentation, raw material R & D and manufacturing and terminal preparations. It is a raw material manufacturer and product provider of nattokinase, natural vitamin K2 (MK-7) and food grade hyaluronic acid in China.

100,000 Class

GMP Clean workshop

10,000+

Microbiological testing room

30%

Scientific research team and expert team in research account for 30%

6200+

Bacterial strain in store

10%

10% of the sales revenue is invested in scientific research and development every year

90%

More than 90% of patents are for invention

Milestones

2022

New discoveries - Make life more exciting - Vitamin K2 expert exchange meeting of public welfare project was held in Beijing

Nanao Nattokinase Scientists Forum and "Natto Powder" Group Standard Release Conference were successfully held

The "Expert Suggestions on the Application of Nattokinase in Risk Groups of Vascular Diseases (2020 Edition) " was officially released in cooperation with the Beijing Neurological Society

The T/CQAP group standard of "Natto Powder" (2001-2022) was officially released and implemented in conjunction with the Pharmaceutical Quality Management Association of China

On the first anniversary of the establishment of "Kangbai Micro-ecology Fund", Sungen donated 2 million yuan to increase the capital

Launched the “Columbus Project of Probiotic” to openly collect clinical research projects on probiotics

2021

Establish the “Kangbai Micro-ecology Fund”

Breakthrough in scientific research achievements of 120 billion active probiotics

Obtain license of sodium hyaluronate food production. Launch food grade sodium hyaluronate raw material HAUni ™

Establish “The Research Center of HA Food Application", jointing Junyue Health

Publish the book “Clinial Vitamin K2 Theory”

Launch the public welfare activities "NOT WITHOUT YOU, Caring for cardiovascular and cerebrovascular health”

Establish Sungen Shanghai office

2020

Publish scientific research achievements of 120 billion active probiotics

Start the special fund for nutrition promotion of China Health Promotion Foundation - Sungen scientific research fund project of vitamin K2

The first expert seminar on "The Application of Nattokinase in People at Risk of Vascular Disease” (2020 Edition) was held jointly with Beijing Society of Neurology

2019

Formulate the “Local Food Safety Standard of Guangdong Province-natto Powder”, and unify the activity detection standard of nattokinase in domestic

Successfully developed international single crystal of vitamin K2 and high activity odorless raw materials of nattokinase

Cooperate with Shenyang Pharmaceutical University to develop "Class I new biological products about nattokinase injection and oral preparation"

The book "Expert Consensus on the Role of Vitamin K2 in Disease Prevention and Treatment" was published

Awarded CNIC 2019 “Award for Health Industry Ingenuity Enterprise "

Sungen scientific research fund project of vitamin K2 was selected as “Top Ten Positive Energy Events in Nutrition and Health Market in 2019"

Raw material of vitamin K2 (MK-7) was rated as "High-tech Product in Guangdong" in 2019

2018

Establish “Antithrombotic and Thrombolytic Innovative Drug Research Center of Sungen-Shenyang Pharmaceutical University "

Publish the popular science book “Vitamin K2 -- A Forgotten Vitamin"

Awarded CNIC 2018 “Industry Promotion Award of Vitamin K2 "

Sunshine consumption and multi center clinical real world research action were selected as “Top Ten Positive Energy Events in Nutrition and Health Market in 2018 "

2017

Establish the “Vitamin K2 Research Fund" and launch the first batch research projects of vitamin K2

Awarded the title of “Production Management Demonstration Base of Natto Physiological Active Substance" in Chinese mainland

Inaugurate the "Vitamin K2 Research Center" and launch the first six vitamin K2 research projects

Publish book “Clinical Data Collection”

2016

Purification technology of vitamin K2 has won the national invention patent, and vitamin K2 has obtained the EU new resource food certification

The application for vitamin K2 included in the national nutrition fortifier catalogue (14880) was officially approved

Obtained the first production license of vitamin K2 in China

2015

Obtain first export health certificate of vitamin K2 in China and become the first enterprise to officially declare for export in the name of vitamin K2 in China

Apply for EU new resource food certification and US FDA certification

2014

Pass ISO and HACCP double certification

2012

Awarded the title of “Production Quality Management Demonstration Base of Nattokinase " in China

Establish the "Pamir Plateau Institute of Medicinal Plants" with Xinjiang Uygur Institute of medicine

The preclinical study of a new anticancer drug Weikang alcohol was approved as a project of major new anticancer drug in Guangdong Province

Nattokinase, a new thrombolytic drug, was approved as a research project of major new cardiovascular and cerebrovascular drugs in Guangdong Province

2011

The Organizing Committee of the high tech fair rated Chongjian series products as "High-tech Achievements" and designated them as participating health products

Be rated as a national high-tech enterprise

2006-2010

"Production of paclitaxel by fermentation of genetically engineered strain ST026 "won the bid for " Key breakthrough projects in key fields in Guangdong and Hong Kong in 2006 "

Become the flagship manufacturer of raw materials of nattokinase (EsseZyme ™） and natural vitamin K2 (ESSEK2™） in China

Pass GMP / QS certification

"Production of paclitaxel by fermentation of genetically engineered strain ST026 " has won 4 invention patents at home and abroad

Weikang alcohol, a new anticancer active molecule, has won the national major research and development project of new anticancer drugs, and four invention patents at home and abroad

Become a Chinese mainland member unit of Taiwan nattokinase Association

2000-2005

Complete the acceptance of the project of Ministry of Science and Technology "Production of anticancer drug paclitaxel by fermentation with genetic engineering strain Phargen AA-026"

Sign the agreement on co-construction of “Joint Laboratory of secondary metabolism engineering” with Institute of Botany, Chinese Academy of Sciences

Sign "the cooperation agreement of Anticoagulant drug - genetically engineered recombinant hirudin (Zhibaosu™，Hirudin ™）" with Peking University

1989-1999

"Production of anticancer drug paclitaxel by fermentation with genetic engineering strain Phargen AA-026" won the first batch of financial support of the innovation fund project of the Ministry of scientific research in China

Discover a new anticancer drug molecule Weikang alcohol, complete the structure confirmation and apply for invention patent

Pilot studies and approvals of genetically engineered peptide drugs G-CSF and IL-1ra

Dr. Chen Jiepengs team conduct peptide drugs and paclitaxel research projects at Peking University

2022

2021

2020

2019

2018